bi-shMSLN (Gradalis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebi-shMSLN (Gradalis)
Drug Alias Namebi-shRNA MSLN (Gradalis)bi-functional mesothelin shRNA (Gradalis)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionMesothelin inhibitors
TargetsMesothelin
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGradalis Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGradalis IncBaylor College Of Medicine
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A